Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/Neck Cancer
Condition(s):Recurrent Head and Neck CancerLast Updated:August 31, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Recurrent Head and Neck CancerLast Updated:August 31, 2023Recruiting
Condition(s):Multiple SclerosisLast Updated:April 27, 2023Recruiting
Condition(s):MyelomaLast Updated:December 28, 2021Not yet recruiting
Condition(s):Acute Myeloid Leukemia; Core-Binding FactorLast Updated:May 11, 2022Recruiting
Condition(s):Acute Myeloid Leukemia; Myelodysplastic SyndromesLast Updated:October 24, 2023Recruiting
Condition(s):Acute Myeloid Leukemia, Adult; Myelodysplastic Syndrome(MDS); Allogeneic Hematopoietic Stem Cell TransplantationLast Updated:January 6, 2023Recruiting
Condition(s):Primary Central Nervous System LymphomaLast Updated:February 29, 2024Recruiting
Condition(s):Hematologic Malignancy; Older Patients; Allogeneic Hematopoietic Stem Cell TransplantationLast Updated:October 27, 2021Recruiting
Condition(s):Hematological Malignancy; Multiple MyelomaLast Updated:December 20, 2023Recruiting
Condition(s):Recurrent Acute Myeloid Leukemia; Recurrent Juvenile Myelomonocytic Leukemia; Recurrent Myelodysplastic Syndrome; Refractory Acute Myeloid Leukemia; Refractory Myelodysplastic SyndromeLast Updated:February 8, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.